We previously demonstrated that inhibition of EEF1A1 with DB reduced hepatic steatosis in diet-induced obese mice with MASLD, and furthermore that DB decreased the proliferation and function in vitro of cell types that would contribute to liver inflammation and fibrosis (47). Here, EEF1A1 is linked to fatty liver disease.